Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,308 | -15,848 | -13,320 | -8,031 | -27,089 |
| Depreciation Amortization | 995 | 793 | 527 | 287 | 1,133 |
| Accounts receivable | -61 | -309 | -82 | -173 | 189 |
| Accounts payable and accrued liabilities | -329 | 57 | 660 | 570 | -438 |
| Other Working Capital | -825 | -1,004 | 562 | 947 | -233 |
| Other Operating Activity | 4,415 | 3,586 | 391 | -300 | -1,147 |
| Operating Cash Flow | $-15,114 | $-12,727 | $-11,262 | $-6,699 | $-27,585 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 39 | 63 | 23 | -28 | -684 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 109 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -2,000 |
| Sale Of Investment | 700 | 700 | 700 | 700 | N/A |
| Investing Cash Flow | $739 | $763 | $723 | $672 | $-2,575 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,517 | 2,517 | 2,517 | 2,517 | 9,014 |
| Debt Repayment | -811 | -602 | -397 | -197 | -140 |
| Common Stock Issued | 2,759 | 2,000 | 2,000 | 1,250 | 7,259 |
| Financing Cash Flow | $6,465 | $3,915 | $4,119 | $3,570 | $16,133 |
| Beginning Cash Position | 10,094 | 10,094 | 10,094 | 10,094 | 24,120 |
| End Cash Position | 2,020 | 1,909 | 3,557 | 7,637 | 10,094 |
| Net Cash Flow | $-8,073 | $-8,184 | $-6,536 | $-2,457 | $-14,027 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,114 | -12,727 | -11,262 | -6,699 | -27,585 |
| Capital Expenditure | -40 | -40 | -28 | -28 | -684 |
| Free Cash Flow | -15,154 | -12,767 | -11,290 | -6,727 | -28,269 |